Neuroprotective Products Market: An insight on the important factors and trends influencing the market

Neuroprotective products are medications that are used to protect or preserve the neuronal structure of the brain from degeneration and injury. These products are extensively used as treatment option for many central nervous system complications such as stroke, neurodegenerative diseases, spinal cord injury and traumatic brain injury. The primary objective of neuroprotective products is to decrease the dysfunction of neurons after a brain injury and also to retain the integrity of cellular functions in the brain.

Read Full Report: http://www.transparencymarketresearch.com/neuroprotective-products-market.html

Neuroprotective products can be classified as follows:

Anti-excitotoxic agents
Anti-inflammatory agents
Metal ion chelators
Neurotropic factors
Ion channel modulators
Gene therapy
Apoptosis inhibitors
Free radical trappers
Mitochondrial dysfunction regulators

Neuroprotective products are used in various medical conditions which are as follows:

Alzheimer's Disease
Ocular Degeneration
Brain Injury
Multiple Sclerosis
Huntington's Disease
Parkinson's Disease
Amyotrophic Lateral Sclerosis
Peripheral neuropathy

The primary factors driving this market are rise in incidence and prevalence rate of neurodegenerative diseases such as Parkinson's disease, Amyotrophic lateral sclerosis, Huntington's disease and Alzheimer's disease. Moreover, rise in demand for enhanced medications for brain injuries is expected to stimulate the market growth. However, stringent regulatory approvals and high development costs is likely to hinder the growth of the market.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1976

In the geographical perspective, North America is the primary market owing to the increased numbers of neurodegenerative disorder cases. According to the Alzheimer’s Association (AA), approximately 5.4 million people in the United States are suffering from Alzheimer’s disease (AD) as of 2012. Moreover, according to the Parkinson's Disease Foundation, each year around 60,000 Americans are diagnosed with Parkinson’s disease due to which the market is expected to witness a significant growth rate. Furthermore, the Europe and Asia-Pacific regions are estimated to experience an increased market growth due to commercialization of personalized medication for neurodegenerative disorders.

Some of the market players in this industry segment are BHR Pharma LLC, Genervon Biopharmaceuticals LLC, NeuroVive Pharmaceutical AB, Neuren Pharmaceuticals Limited, Allon Therapeutics Inc. and Varinel Inc., amongst others.

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.